©The Author(s) 2026.
World J Cardiol. Feb 26, 2026; 18(2): 114636
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.114636
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.114636
Table 1 Baseline patient characteristics, n (%)/mean ± SD
| Variables | n = 740 patients |
| Age in years | 55.25 ± 10.00 |
| Gender | |
| Male | 612 (82.70) |
| Female | 128 (17.29) |
| Heart rate (bpm) | 80.20 ± 10.57 |
| Blood pressure (mmHg) | |
| Diastolic | 77.12 ± 8.57 |
| Systolic | 121.8 ± 15.29 |
| Sr creatinine (mg/dL) | 1 ± 0.25 |
| eGFR (mL/minute/1.73 m2) | 86.36 ± 20.60 |
| Hb (g/dL) | 13.19 ± 1.66 |
| LVEF (%) | 46.10 ± 11.00 |
| Chronic stable angina | 134 (18.10) |
| Acute coronary syndrome | 606 (81.89) |
| STEMI | 361 (48.78) |
| NSTEMI | 80 (10.81) |
| Unstable angina | 165 (22.29) |
| Hypertension | 203 (27.43) |
| Diabetes mellitus | 182 (24.59) |
| Smoking current | 205 (27.70) |
| Previous stroke | 7 (0.94) |
| Previous MI | 48 (6.48) |
| Previous PCI | 64 (8.64) |
| Previous CABG | 7 (0.94) |
| Patients with renal dysfunction (eGFR < 60) | 63 (8.51) |
- Citation: Trehan VK, Safal S, Trehan S, Kathuria S, Vani PS. Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy. World J Cardiol 2026; 18(2): 114636
- URL: https://www.wjgnet.com/1949-8462/full/v18/i2/114636.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i2.114636